A Pilot Study to Investigate if Frequency of Therapy Alters Outcomes of the Lee Silverman Voice Treatment (LSVT) Programme for Patients with Parkinson's Disease

ISRCTN ISRCTN40910122
DOI https://doi.org/10.1186/ISRCTN40910122
Secondary identifying numbers N0016131978
Submission date
30/09/2004
Registration date
30/09/2004
Last edited
07/09/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Not provided at time of registration

Contact information

Ms Deirdre Cotter
Scientific

Department of Speech and Language Therapy
Hammersmith Hospital
Du Cane Road
London
W12 0HS
United Kingdom

Phone +44 (0)208 383 3076
Email abc@email.com

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA Pilot Study to Investigate if Frequency of Therapy Alters Outcomes of the Lee Silverman Voice Treatment (LSVT) Programme for Patients with Parkinson's Disease
Study hypothesisA Pilot Study to Investigate if Frequency of Therapy Alters Outcomes of the Lee Silverman Voice Treatment (LSVT) Programme for Patients with Parkinson's Disease
Ethics approval(s)Not provided at time of registration
ConditionNervous System Diseases: Parkinson's disease
InterventionNot provided at time of registration
Intervention typeOther
Primary outcome measurePublication
Secondary outcome measuresNot provided at time of registration
Overall study start date08/08/2003
Overall study end date10/01/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants27
Participant inclusion criteria1. Patients entering the study will have volunteered for the study and will have agreed to be randomly allocated to either a control group or one of two treatment groups.
2. A diagnosis of idiopathic PD
3. Categorised between stages 1 to 4 on the `Functional Rating Scale for Parkinson's Disease¿, Hoehn & Yahr (1967)
4. Neuropharmacologically stable before and during treatment
5. Fluent English speakers
6. Intelligibility of speech will have received a rating of between 5 and 9 on the Parkinson¿s disease disability rating scale. (Yorkston 1995)
Participant exclusion criteria1. Any history of a language deficit caused by a past event such as a cardiovascular event
2. Evidence of a cognitive deficit on the `Mini-Mental State Examination (score >24), Folstein et al 1975
3. Evidence of depression on the Beck Depression inventory (score <14), Beck & Beck 1972.
4. History of a chronic hearing loss or report/suspected hearing loss
5. History of laryngeal disease and will be free of acute cardiac and respiratory conditions during the study
Recruitment start date08/08/2003
Recruitment end date10/01/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Hammersmith Hospital
London
W12 0HS
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Hospital/treatment centre

Hammersmith Hospital NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan